p53-dependent expression of PIG3 during proliferation, genotoxic stress, and reversible growth arrest

Cancer Letters

Volumn 156, Issue 1, 2000, Pages 63-72

  Flatt, Patricia M ^a   Polyak, Kornelia ^b   Tang, Luo Jia ^a   Scatena, Caroline D ^a   Westfall, Matthew D ^a   Rubinstein, Laura A ^c   Yu, Jian ^b   Kinzler, Kenneth W ^b   Vogelstein, Bert ^b   Hill, Dave E ^c   Pietenpol, Jennifer A ^a  

^a Center in Molecular Toxicology   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c Oncogene Research Products   (United States)

Author keywords

Localization; Oxidoreductase; p53 inducible; Protein

Indexed keywords

ANTIBODY; OXIDOREDUCTASE; PROTEIN; PROTEIN P53;

ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; COLORECTAL CARCINOMA; GENOTOXICITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION;

APOPTOSIS; CELL CYCLE; CELL DIVISION; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DOXORUBICIN; GENE EXPRESSION REGULATION; HUMANS; NUCLEAR PROTEINS; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034256962     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00441-9     Document Type: Article

References (37)

1. Kern S.E., Kinzler K.W., Bruskin A., Jarosz D., Friedman P., Prives C., Vogelstein B. Identification of p53 as a sequence-specific DNA-binding protein. Science. 252:1991;1708-1710.
2. Pietenpol J.A., Tokino T., El-Deiry W.S., Kinzler K.W., Vogelstein B. Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. USA. 91:1994;1998-2002.
3. El-Deiry W.S., Kern S.E., Pietenpol J.A., Kinzler K.W., Vogelstein B. Definition of a consensus binding site for p53. Nat. Genet. 1:1992;45-49.
4. Giaccia A.J., Kastan M.B. The complexity of p53 modulation: Emerging patterns from divergent signals. Genes Dev. 12:1998;2973-2983.
5. 1 arrest and apoptosis. Cancer Res. 54:1994;1169-1174.
6. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell. 82:1995;675-684.
7. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 366:1993;701-704.
8. Brugarolas J., Chandrasekaran C., Gordon J.I., Beach D., Jacks T., Hannon G.J. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature. 377:1995;552-557.
9. Hermeking H., Lengauer C., Polyak K., He T.-C., Zhang L., Thiagalingam S., Kinzler K.W., Vogelstein B. 14-3-3σ is a p53-regulated inhibitor of G2/M progression. Mol. Cell. 1:1998;3-11.
10. Blumberg P.M., Driedger P.E., Rossow P.W. Effect of a phorbol ester on a transformation-sensitive protein of chick fibroblasts. Nature. 264:1976;446-447.
11. Carrier F., Georgel P.T., Pourquier P., Blake M., Kontny H.U., Antinore M.J., Gariboldi M., Myers T.G., Weinstein J.N., Pommier Y., Fornace A.J. Jr. Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin, Mol. Cell. Biol. 19:1999;1673-1685.
12. Buckbinder L., Talbott R., Velasco-Miguel S., Takenaka I., Faha B., Seizinger B.R., Kley N. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature. 377:1995;646-649.
13. Zhan Q., Fan S., Bae I., Guillouf C., Liebermann D.A., O'Connor P.M., Fornace A.J. Jr. Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene. 9:1994;3743-3751.
14. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80:1995;293-299.
15. Wu G.S., Burns T.F., McDonald E.R. III, Jiang W., Meng R., Krantz I.D., Kao G., Gan D.D., Zhou J.Y., Muschel R., Hamilton S.R., Spinner N.B., Markowitz S., Wu G., El-Deiiy W.S. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat. Genet. 17:1997;141-143.
16. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., Vogelstein B. model for p53-induced apoptosis. Nature. 389:1997;300-305.
17. Venot C., Maratrat M., Dureuil C., Conseiller E., Bracco L., Debussche L. The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression. EMBO J. 17:1998;4668-4679.
18. 2 arrest after DNA damage. Science. 282:1998;1497-1501.
19. 1 arrest in human cancer cells. Cancer Res. 55:1995;5187-5190.
20. Chen A.C., Guo X., Derguini F., Gudas L.J. Human breast cancer cells and normal epithelial cells: Retinol metabolism and growth inhibition by the retinol metabolite 4-oxoretinol. Cancer Res. 57:1997;4642-4651.
21. Flatt P.M., Price J.O., Shaw A., Pietenpol J.A. Differential cell cycle checkpoint response in normal human keratinocytes and fibroblasts. Cell Growth Differ. 9:1998;535-543.
22. Waf1/Cip1 inhibition of cyclin E/Cdk2 activity prevents endoreduplication after mitotic spindle disruption. Mol. Cell. Biol. 19:1999;205-215.
23. Wang H-G., Rapp U.R., Reed J. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell. 87:1996;629-638.
24. Kessis T.D., Slebos R.J., Nelson W.G., Kastan M.B., Plunkett B.S., Han S.M., Lorincz A.T., Hedrick L., Cho K.R. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc. Natl. Acad. Sci. USA. 90:1993;3988-3992.
25. Scheffner M., Huibregtse J.M., Vierstra R.D., Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell. 75:1993;495-505.
26. Rao P.V., Krishna C.M., Zigler J.S. Identification and characterization of the enzymatic activity of ζ-crystallin from guinea pig lens. J. Biol. Chem. 267:(1):1992;96-102.
27. Ross D. Quinone reductases. Sipes G., McQueen C.A., Gandolfi A.J., Guengerich F.P. Comprehensive Toxicology. Biotransformation. Vol. 3:1997;179-197 Elsevier, New York.
28. Johnson T.M., Yu Z.X., Ferrans V.J., Lowenstein P.A., Finkel T. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc. Natl. Acad. Sci. USA. 93:1996;11848-11852.
29. Li P.F., Dietz R., von Harsdorf R. p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J. 18:(21):1999;6027-6036.
30. Yin Y.X., Terauchi Y., Solomon G.G., Aizawa S., Rangarajan P.N., Yazaki Y., Kadowaki T., Barrett J.C. Involvement of p85 in p53-dependent apoptotic response to oxidative stress. Nature. 391:1998;707-710.
31. Flatt P., Pietenpol J.A. Mechanisms of cell cycle checkpoints: At the crossroads of carcinogenesis and drug discovery. Drug Metab. Rev. 2000;. in press.
32. Sun X., Ross D. Quinone-induced apoptosis in human colon adenocarcinoma cells via DT-diaphorase mediated bioactivation. Chem. Biol. Interact. 100:(3):1996;267-276.
33. Ross D., Siegel D., Beall H., Prakash A.S., Mulcahy R.T., Gibson N.W. DT-diaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C. Cancer Metastasis Rev. 12:(2):1993;83-101.
34. Powis G. Metabolism and reactions of quinoid anticancer agents. Pharmacol. Ther. 35:1987;57-162.
35. Berger M.S., Talcott R.E., Rosenblum M.L., Silva M., Ali-Osman F., Smith M.T. The use of quinones in brain tumor chemotherapy. Preliminary results form preclinical investigations. J. Toxicol. Environ. Health. 16:1999;713-719.
36. Radjendirane V., Joseph P., Lee Y.H., Kimura S., Klein-Szanto A.J.P., Gonzalez F.J., Jaiswal A. Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity. J. Biol. Chem. 273:(13):1998;7382-7389.
37. Szak S.T., Pietenpol J.A. "Trapping" p53 at promoter sites: Kinetics and post-translational modifications. 2000;. Submitted for publication.